Cognetix cognetix.com


Public list: Pharma Startups (6570) Neuroscience Startups (947)

Cognetix is a biopharmaceutical company that is developing peptide therapeutics for the treatment of epilepsy, pain and anesthesia. The company's research and development efforts are focused on conopeptides which are peptides derived from the venom of predatory sea snails. Per the company, Cognetix has corporate collaborations in place with Medtronic, Inc. and Elan Corporation plc.

Cognetix is a biopharmaceutical company that is developing peptide therapeutics for the treatment of epilepsy, pain and anesthesia. The company's research and development efforts are focused on conopeptides which are peptides derived from the venom o...Show all

Company (Alive / Active)

Phone: 801-581-0400

Fax:

421 Wakara Way
Suite 201
Salt Lake City, 84108
Utah, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cognetix $17M Jul 6, 2001
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cognetix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Arcion Therapeutics

Baltimore, Maryland, United States
Alive / ActiveArcion Therapeutics applies breakthroughs in neuroscience to advance the treatment of chronic pain. The company focuses on topical treatments to provide pain relief with convenient application and reduced systemic side effects. Arcion's core technology is based on research which showed that in many neuropathic pain conditions, the signal that triggers pain actually arises at the level of the skin. This finding provides a strong biological rationale for developing topically delivered drugs to tar...Show allLogin to see details

Neuromed Pharmaceuticals

Vancouver, British Columbia, Canada
MergedLaunched in 1998, Neuromed is a biopharmaceutical company focused on the development of small molecule drugs targeting neuronal calcium channels to treat neurological disorders with the initial emphasis on chronic pain anxiety and strokeLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
�-conotoxin peptides Jun 06, 2013 May 27, 2014 Patent
�-conotoxin peptides Oct 09, 2007 Feb 23, 2010 Patent